« Back to Record
Citation APA

Duerinck, J., Bouttens, F., Verschaeve, V., Neyns, B., Du Four, S., Vandervorst, F., D'Haene, N., Le Mercier, M., Michotte, A., Van Binst, A., Everaert, H., & Salmon, I. (2016). Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma. Journal of neuro-oncology, 128(1), 147-155. doi:10.1007/s11060-016-2092-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231984

Duerinck, J., Bouttens, F., Verschaeve, V., Neyns, B., Du Four, S., Vandervorst, F., D'Haene, N., Le Mercier, M., Michotte, A., Van Binst, A., Everaert, H., & Salmon, I. (2016). Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma. Journal of neuro-oncology, 128(1), 147-155. doi:10.1007/s11060-016-2092-2